Claudineia Almeida de Souza

Claudineia Almeida de Souza

Auto-generated profile, based on publicly available information

Claudineia Almeida de Souza

Universidade Federal da Bahia, Brazil

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2023 in Nutrition Reviews
Verified
Journal Article
Closed access
PDF file
NANaiade Silveira Almeida
Naiade Silveira Almeida
RRRaquel Rocha
Raquel Rocha
CSClaudineia Almeida de Souza
Claudineia Almeida de Souza
CDCarla Daltro
Carla Daltro
Priscila Ribas De Farias CostaPriscila Ribas De Farias Costa
Priscila Ribas De Farias Costa
HELMA PINCHEMEL COTRIMHELMA PINCHEMEL COTRIM
HELMA PINCHEMEL COTRIM
Context: There is growing evidence that insufficient dietary intake is associated with sarcopenia. Objective: In this systematic review and meta-analysis, the energy and nutrient intakes by people with and without sarcopenia were compared using only the European Working Group on Sarcopenia in Older People 2010 (EWGSOP1) and 2019 (EWGSOP2) consensus diagnostic criteria. Data Sources: Only observational studies that compared energy and nutrient intake from food alone by individuals with and without sarcopenia were included. Studies were searched in the following databases: Embase, PubMed, Scopus, Web of Science, Lilacs, Ovid, and Scopus. The review followed the PRISMA checklist and submitted the protocol to PROSPERO. Data Extraction: Data were extracted by 2 authors independently. The methodological quality of the studies was assessed using the Newcastle-Ottawa scale. Data Analysis: A total of 8648 articles were identified and 12 were selected. Among individuals with sarcopenia, lower intakes of energy and some nutrients, mainly with antioxidant properties, were observed compared with those without sarcopenia. Meta-analyses showed that individuals with sarcopenia consume fewer calories/day than individuals without sarcopenia (n = 10 studies; standardized mean difference (SMD) −0.15; 95% confidence interval: −0.29, −0.01) diagnosed by EWGSOP1 and EWGSOP2. Individuals with sarcopenia consume less omega-3, folate, magnesium, phosphorus, selenium, zinc, and vitamins C, D, and E when compared with those without sarcopenia. Conclusion: The results of the present study suggest that insufficient intake of energy and nutrients with antioxidant potential may be associated with sarcopenia. Systematic Review Registration: PROSPERO registration no. CRD 42020195698.

1 November 2021 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
NANaiade Silveira Almeida
Naiade Silveira Almeida
RRRaquel Rocha
Raquel Rocha
CDCarla Daltro
Carla Daltro
CSClaudineia Almeida de Souza
Claudineia Almeida de Souza
RSRafael Leiróz Pereira Duarte Silva
Rafael Leiróz Pereira Duarte Silva
HELMA PINCHEMEL COTRIMHELMA PINCHEMEL COTRIM
HELMA PINCHEMEL COTRIM
OBJECTIVE: This study aims to evaluate the role of anthropometric clinical indicators of visceral adiposity as predictors of NAFLD, identifying the cutoff points based on gender. METHODS: This was a cross-sectional study conducted in patients with or without NAFLD. Waist circumference (WC), body mass index (BMI), waist-to-height ratio (WHtR), Conicity Index (C Index), and lipid accumulation product (LAP) were evaluated. RESULTS: A total of 107 individuals were evaluated, of which 46.7% were diagnosed with NAFLD. Individuals with NAFLD presented higher values of WC, BMI, C Index, LAP, and WHtR when compared with those without NAFLD (p<0.05). For the total sample, the indicators WC, BMI, WHtR, LAP, and C Index had an area under the receiver operator characteristic curve (AUC) above 0.87, with no difference in the prediction of NAFLD in both sexes. WHtR (AUC=0.934) was the indicator of visceral adiposity with the best discriminatory power for NAFLD, followed by LAP (0.919), WC (0.912), C Index (0.907), and BMI (0.877). CONCLUSIONS: The anthropometric clinical indicators of visceral adiposity showed high performance, especially the WHtR indicator, as NAFLD predictors.

1 March 2022 in Arquivos de Gastroenterologia
Verified
Journal Article
Open access
CSClaudineia Almeida de Souza
Claudineia Almeida de Souza
RRRaquel Rocha
Raquel Rocha
Priscila Ribas De Farias CostaPriscila Ribas De Farias Costa
Priscila Ribas De Farias Costa
NANaiade Silveira Almeida
Naiade Silveira Almeida
HELMA PINCHEMEL COTRIMHELMA PINCHEMEL COTRIM
HELMA PINCHEMEL COTRIM
Background Supplementation with probiotics, prebiotics and symbiotics has shown positive effects on clinical markers and risk factors for non-alcoholic fatty liver disease (NAFLD). Objective To evaluate the effect of supplementation with probiotic, prebiotic or symbiotic on intestinal microbiota in NAFLD patients. Methods Two investigators conducted independently search for articles in the Medline databases, via PubMed, Web of Science, Embase, Scopus, Lilacs, Central Cochrane Library, Clinical Trials.gov and on the Ovid platform for the gray literature search. Results A total of 3,423 papers were identified by searching the electronic databases; 1,560 of them were duplicate and they were excluded; 1,825 articles were excluded after reading the title and A total of 39 articles were select to reading, however only four articles met the eligibility criteria to include in this systematic review. Three of the included studies that used prebiotic or symbiotic supplementation showed that after the intervention there were changes in the intestinal microbiota pattern. Only in one study such changes were not observed. A high risk of bias was observed in most assessments. Conclusion Although there is a possible change in the gut microbiota of individuals with NAFLD after supplementation with symbiotics or prebiotics, a clinical indication as part of NAFLD treatment is not yet possible.

1 September 2021 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
IBIasmin dos Santos Barreto
Iasmin dos Santos Barreto
RSRaquel Oliveira dos Santos
Raquel Oliveira dos Santos
RRRaquel Rocha
Raquel Rocha
CSClaudineia de Souza
Claudineia de Souza
NANaiade Silveira Almeida
Naiade Silveira Almeida
HELMA PINCHEMEL COTRIMHELMA PINCHEMEL COTRIM
HELMA PINCHEMEL COTRIM
OBJECTIVE: To evaluate the association between muscle mass depletion and compromising of the cell membrane integrity and clinical-anthropometric characteristics in patients with nonalcoholic fatty liver disease. METHODS: This observational study evaluated waist circumference, body mass index, and waist-to-height ratio in patients with nonalcoholic fatty liver disease. Skeletal mass index corrected by weight and impairment of cell membrane integrity were assessed using bioelectrical impedance analysis. RESULTS: In 56 patients, muscle mass depletion was observed in 62.5% and cell membrane impairment in 28.6%. The metabolic syndrome and elevated aspartate aminotransferase were the only clinical factors associated with mass depletion (p<0.05). The linear regression analysis showed association between skeletal mass index and waist-to-height ratio and waist circumference, after adjustments (p0.05). CONCLUSIONS: The prevalence of mass depletion and cell membrane impairment was higher in patients with nonalcoholic fatty liver disease. The muscle mass depletion was associated with central obesity, aspartate aminotransferase elevated, and metabolic syndrome; however, the phase angle is not associated with clinical and anthropometric data.

18 February 2026 in Research Square
Verified
Preprint
Open access
CSClaudineia Almeida de Souza
Claudineia Almeida de Souza
RRRaquel Rocha
Raquel Rocha
LVLuiza Valois Vieira
Luiza Valois Vieira
NANaiade Silveira Almeida
Naiade Silveira Almeida
CDCarla Daltro
Carla Daltro
HELMA PINCHEMEL COTRIMHELMA PINCHEMEL COTRIM
HELMA PINCHEMEL COTRIM
Background : Ultra-processed foods (UPFs) are industrial formulations characterized by a high processing with the addition of food additives. Consumption of UPFs has been associated with adverse metabolic outcomes, including metabolic dysfunction-associated steatotic liver disease (MASLD). Lifestyle changes, including weight loss combined with caloric restrictions are central therapeutic strategies for metabolic control, qualitative dietary modifications may be crucial for the management of MASLD. Objectives : to determine the prevalence of UPFs consumption among patients with MASLD in outpatient follow-up and to assess its contribution to energy intake. Patients and Methods : This cross-sectional study included patients diagnosed with MASLD, who were followed at a hepatology outpatient clinic. Sociodemographic, clinical, and anthropometric data were collected. Dietary intake was assessed using three 24-hour dietary recalls and classified according to NOVA system to quantify the contribution of UPFs to total caloric and nutrient intake. Results : Ninety-seven patients with MASLD were evaluated, women (78.4%), with a high frequency of obesity (60.8%), type 2 diabetes (52.6%), and systemic arterial hypertension (SAH) (56.7%). UPFs consumption ranged from 0.0% to 41.0% of total caloric intake. Higher UPF consumption was associated with lack of paid employment, whereas lower UPFs consumption was associated with the presence of type 2 diabetes (p < 0.05). Carbohydrates, total fats, and proteins derived from UPFs showed a strong positive correlation with caloric intake, with carbohydrates representing the main energy source. Conclusions : Consumption of UPFs was relevant in this sample of patients with MASLD, with energy intake derived from carbohydrates and total fats.